Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapan-Dia trial of dapansutrile in adults with type 2 diabetes mellitus
2024-511828-14-00Phase 2Authorised
- Sponsor
- Kantonsspital Baden
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Dapansutrile with Placebo (2 arms). Primary endpoint: Change from baseline in HbA1c at Week 26. Planned start May 2025; status: authorised.
02
Drugs
dapansutrile
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2024-511828-14-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511828-14-00.